Literature DB >> 2878884

Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.

R L Friedman, R L Fiederlein, L Glasser, J N Galgiani.   

Abstract

Affinity-purified adenylate cyclase (AC) of Bordetella pertussis, free of contaminating pertussis toxin, was demonstrated to have biological effects on human polymorphonuclear leukocytes (PMN). AC at doses of 25 and 50 micrograms/ml increased intracellular cAMP levels in the phagocytes 7.6- to 23.5-fold, respectively, above basal levels. AC inhibited PMN chemiluminescence, chemotaxis, and superoxide production in a dose-dependent manner. The 50% inhibitory dose for chemotaxis and chemiluminescence was 36.5 micrograms/ml; for superoxide generation it was 71.0 micrograms/ml. Although these PMN metabolic functions were impaired, no effect on phagocytic activity was observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2878884      PMCID: PMC260291          DOI: 10.1128/iai.55.1.135-140.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities.

Authors:  S Utsumi; S Sonoda; T Imagawa; M Kanoh
Journal:  Biken J       Date:  1978-12

Review 2.  Cyclic AMP and the immune response;.

Authors:  C W Parker; T J Sullivan; H J Wedner
Journal:  Adv Cyclic Nucleotide Res       Date:  1974

3.  Activation of thyroid membrane adenylate cyclase by purine nucleotides.

Authors:  J Wolff; G H Cook
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

4.  Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin.

Authors:  G M Bokoch; A G Gilman
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

5.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Authors:  B D Meade; P D Kind; J B Ewell; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Pertussis.

Authors:  L C Olson
Journal:  Medicine (Baltimore)       Date:  1975-11       Impact factor: 1.889

7.  Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization.

Authors:  E Hewlett; J Wolff
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

8.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Effects of anthrax toxin components on human neutrophils.

Authors:  J O'Brien; A Friedlander; T Dreier; J Ezzell; S Leppla
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

10.  ADP-ribosylation of the specific membrane protein by islet-activating protein, pertussis toxin, associated with inhibition of a chemotactic peptide-induced arachidonate release in neutrophils. A possible role of the toxin substrate in Ca2+-mobilizing biosignaling.

Authors:  F Okajima; M Ui
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

View more
  42 in total

1.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

Authors:  L L Steed; E T Akporiaye; R L Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.

Authors:  Pádraig J Ross; Ed C Lavelle; Kingston H G Mills; Aoife P Boyd
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

4.  Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.

Authors:  Annika Elomaa; Abdolreza Advani; Declan Donnelly; Mia Antila; Jussi Mertsola; Hans Hallander; Qiushui He
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 5.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

8.  Adenosine and 2-phenylaminoadenosine (CV-1808) inhibit human neutrophil bactericidal function.

Authors:  G E Hardart; G W Sullivan; H T Carper; G L Mandell
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

10.  Bordetella adenylate cyclase toxin mobilizes its beta2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps.

Authors:  Ladislav Bumba; Jiri Masin; Radovan Fiser; Peter Sebo
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.